Sökning: "Inflammatory biomarkers"
Visar resultat 6 - 10 av 249 avhandlingar innehållade orden Inflammatory biomarkers.
6. The Temporomandibular Joint in Juvenile Idiopathic Arthritis : Psychosocial, clinical, imaging and parotid saliva biomarkers
Sammanfattning : Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in children. The disease can affect the temporomandibular joint (TMJ) and cause orofacial growth disturbances, pain, and jaw dysfunction. TMJ arthritis is often asymptomatic and therefore a challenging joint to diagnose. LÄS MER
7. Chronic lymphocytic leukemia : Studies on cardiovascular disease, biomarkers and subclones
Sammanfattning : The treatment of Chronic lymphocytic leukemia (CLL) is rapidly changing, with targeted therapies, e.g. Bruton’s tyrosine kinase inhibitors (BTKi), entering the frontline and relapse setting. However, BTKis have significant adverse effects, most notably cardiovascular disease (CVD). LÄS MER
8. Inflammatory biomarkers in ANCA-associated vasculitis
Sammanfattning : Background: Antineutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV) is a heterogenous group of relatively rare and serious small vessel vasculitides, characterized by the presence of proteinase 3 (PR3) ANCA or myeloperoxidase (MPO) ANCA. The disease manifestations vary widely, from a localized form to a serious disease with multi-organ failure. LÄS MER
9. New Biomarkers for Neuromuscular Function and Myasthenia Gravis
Sammanfattning : Myasthenia gravis (MG) is an autoimmune disorder, which is caused by autoantibodies against the acetylcholine receptor (AChR). The cardinal symptom is muscle fatigue, which can range from slight weakness of the extraocular muscles (causing droopy eyelids or double vision), to paralysis of the respiratory muscles. LÄS MER
10. Invasive treatment of renal artery stenosis - effects on blood pressure, medication, renal function and inflammatory biomarkers
Sammanfattning : Renal artery stenosis (RAS) causes hypertension, decreased glomerular filteration rate (GFR), and renal ischemia. RAS is progressive and causes 5-16% of all cases of renal failure. Prevalence of RAS in patients with hypertension is 1-5%. LÄS MER